Caption Management, LLC Athenex, Inc. Transaction History

Caption Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$5.71 - $15.85 $169,016 - $469,160	-29,600 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$9.6 - $17.75 $110,400 - $204,125	-11,500 Reduced 27.98%	29,600 $452,000
Q3 2019 Nov 14, 2019	BUY	$12.16 - $21.0 $358,720 - $619,500	29,500 Added 254.31%	41,100 $500,000
Q2 2019 Aug 13, 2019	BUY	$9.44 - $19.8 $109,504 - $229,680	11,600 New	11,600 $229,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.